Ara
Toplam kayıt 17, listelenen: 11-17
Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients
(Termedia Publishing House Ltd., 2020)
Introduction: Elevated risk of adverse events in comparison to metallic stents resulted in withdrawal of everolimus-eluting bioresorbable scaffolds (eBVS), known as the most intensively studied BVS. There is a paucity of ...
A novel predictor of radial spasm: Arterial stiffness
(Lippincott Williams & Wilkins, 2018)
ObjectiveIn this study, we aimed to assess the relationship between radial artery spasm (RAS) and arterial stiffness (AS) measured by the oscillometric method.Materials and methodsA total of 123 consecutive patients scheduled ...
Adjusting the QRS duration by body mass index for prediction of response to cardiac resynchronization therapy: Does one QRS size fit all?
(Wiley, 2016)
Background: QRS duration (QRSd) is known to be affected by body weight and length. We tested the hypothesis that adjusting the QRSd by body mass index (BMI) may provide individualization for patient selection and improve ...
Native electrocardiographic qrs duration after cardiac resynchronization therapy: The impact on clinical outcomes and prognosis
(Churchill Livingstone Inc Medical Publishers, 2016)
Background: We investigated whether reversed electrical remodeling (RER), defined as narrowing of the native electrocardiographic QRS duration after cardiac resynchronization therapy (CRT), might predict prognosis and ...
Effect of cardiac resynchronization therapy on mitral valve geometry: A novel aspect as "reversed mitral remodeling"
(Springer, 2018)
Amelioration of the valvular geometry is a possible mechanism for mitral regurgitation (MR) improvement in patients receiving cardiac resynchronization therapy (CRT). We aimed to establish the precise definition, incidence, ...
Long-term results of long segment coronary artery lesions overlapped with novolimus-eluting DESolve scaffold: Disappointment or futuristic?
(Turkish Society of Cardiology, 2021)
Objective: The data on using novolimus-eluting DESolve bioresorbable scaffolds (BVS) for long-segment coronary artery lesions remains insufficient. In this study, our main objective was to assess the long-term effects of ...
How accurate are manufacturers' recommendations in determining ineligibility for transfemoral transcatheter aortic valve implantation?
(Sociedade Portuguesa De Cardiologia, 2023)
Introduction: Up to one-third of patients indicated for transcatheter aortic valve implantation (TAVI) may be unsuitable for transfemoral TAVI (TF-TAVI) according to manufacturers' recommendations and numerous professional ...